Amino acid Metabolism Disorders Treatment Market Expected to Reach $961.8 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Amino acid Metabolism Disorders Treatment Market," The amino acid metabolism disorders treatment market was valued at $630.92 million in 2021, and is estimated to reach $961.8 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031.

Metabolism is the process which the body uses to make energy from the food eaten. Food is made up of proteins, carbohydrates, and fats. The digestive system breaks the food parts down into sugars and acids which are also called as the body's fuel. The body can use this fuel right away, or it can store the energy in the body. If a person has a metabolic disorder, then the metabolism process gets harmed and impacted severely. Amino acids are the organic compounds which contains carboxyl and amine functional groups attached to carbon chain. Amino acid metabolism disorders occurs due to excessive build-up of amino acids such as methionine, homocystine, and phenylalanine in the body. This is attributed to improper metabolism of amino acids. The excessive buildup of amino acids and toxic substances can cause health problems such as brain damage, neurological problems, development problems, depression, and hyperactive disorders. One group of amino acid metabolism disorders include phenylketonuria (PKU) and maple syrup urine disease. Amino acids are "building blocks" that join together to form proteins. If people have one of these disorders, their body may have trouble breaking down certain amino acids. There may also be a problem getting the amino acids into the cells. These problems cause a buildup of harmful substances in the body. That can lead to serious, sometimes life-threatening, health problems. These disorders are usually inherited. A baby who is born with this disease may not have any symptoms right away. Its because the disorders can be so serious. The early diagnosis and treatment are critical. Newborn babies get screened for many of these symptoms by using blood tests. The treatments of the amino acid metabolism disorders may include special diets, medicines, and supplements. Some babies may also need additional treatments if there are complications.

Factors that drive growth of global amino acid metabolism disorders treatment market size include the increase in prevalence of amino acid metabolism disorders, availability of various treatments options, rise in healthcare expenditure, and surge in early stage newborn screening for amino acid metabolism disorders diagnosis. In addition, increase in healthcare expenditure also contributes towards the global amino acid metabolism disorders treatment market growth. However, high cost of treatments for amino acid metabolism disorders is expected to hinder the growth of the amino acid metabolism disorders treatment market size.

The COVID-19 pandemic affected the amino acid metabolism disorders treatment industry in a negative way, like various other pharmaceutical industries were affected. This was due to the significant decline in demand for the amino acid metabolism disorders treatments across several sectors, particularly the health and pharmaceutical sector. The main cause of the interruptions experienced by government, as government was majorly involved in the disease spread preventive measures finding. As a result, the COVID-19 outbreak will slowdown the amino acid metabolism disorders treatment industry growth, which will have a negative effect on the market's value in 2022 and beyond.

By product type, the market is divided into folic acid, vitamin B6 and B12, arginine, thiamine, betaine, sapropterin, and others. The sapropterin segment exhibited the highest growth in 2021, owing to amino acid metabolism disorders treatment market trends like increase in prevalence of phenylketonuria and increase in demand for sapropterin in developed countries such as the U.S. and Germany. However, betaine segment is expected to register highest CAGR of 5.4% from 2022 to 2031, owing to increase in product offering for betaine by key market players.

By indication, the market is classified as phenylketonuria, maple syrup urine disease, citrullinemia, homocystinuria, and argininosuccinic aciduria. The phenylketonuria segment exhibited the highest growth in 2021, owing to increase in prevalence of phenylketonuria and mandatory newborn screening for the diagnosis of phenylketonuria and other amino acid metabolism disorders. However, maple syrup urine disease segment is expected to register highest CAGR of 5.5% from 2022 to 2031, owing to increase in prevalence of maple syrup urine disease and development of new therapies for the treatment of maple syrup urine disease.

By distribution channel, the market is classified as hospital pharmacies, drug stores and retail pharmacies, and online providers. The drug stores and retail pharmacies segment dominated the market in 2021 and is expected to remain dominant during the forecast period. The market growth of this segment driven by increase sell of prescription drugs and OTC drugs. However, online providers is expected to register highest CAGR of 6.0% from 2022 to 2031, owing to shift of patients preference to buy medicine online since the covid pandemic period.

Region wise, North America has the highest amino acid metabolism disorders treatment market share in 2021, and is expected to maintain its lead during the forecast period, owing to increase in demands for sapropterin and Kuvan for amino acid metabolism disorders treatments. Moreover, the North America advances due to availability of treatments and well established healthcare infrastructure. However, Asia-Pacific is expected to register highest CAGR of 5.5% during the amino acid metabolism disorders treatment market forecast period, owing to increase in prevalence amino acid metabolism disorders and rise in patients seeking treatment for amino acid metabolism disorders.

KEY FINDINGS OF STUDY

• Based on product type, the sapropterin segment was highest contributor to the market in 2021.
• On the basis of indication, phenylketonuria dominated the market in 2021, and is expected to continue this trend during the forecast period.
• Based on distribution channel, drug stores and retail pharmacies dominated the market in 2021, and is expected to grow at a CAGR of 3.9% during the amino acid metabolism disorders treatment market analysis period.
• Based on region, North America generated the largest revenue share in 2021, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.